News on Ebixa from BioPortfolio.com http://www.BioPortfolio.com Consolidated Ebixa news from BioPortfolio.com Wed, 10 Feb 2010 05:53:44 GMT en Scans hold potential to observe moving target of degenerationhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947268&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947268&THISHREF=http://c.moreover.com/click/here.pl%3fz2487952010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3947268&HITNO=0&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3947268&THISHREF=http://c.moreover.com/click/here.pl%3fz2487952010%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIrish Medical Times: Pfizer/Medivation's Dimebon could generate peak annual sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893647&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893647&THISHREF=http://c.moreover.com/click/here.pl%3fz2460676899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3893647&HITNO=1&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3893647&THISHREF=http://c.moreover.com/click/here.pl%3fz2460676899%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Letter: Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892744&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892744&THISHREF=http://c.moreover.com/click/here.pl%3fz2460378730%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892744&HITNO=2&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892744&THISHREF=http://c.moreover.com/click/here.pl%3fz2460378730%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Pfizer/Medivation's AD drug Dimebon may garner peak year sales of $1.5 billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892738&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892738&THISHREF=http://c.moreover.com/click/here.pl%3fz2460377271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892738&HITNO=3&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892738&THISHREF=http://c.moreover.com/click/here.pl%3fz2460377271%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: For The Treatment Of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales Of $1.5Bhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892028&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892028&THISHREF=http://c.moreover.com/click/here.pl%3fz2460017347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3892028&HITNO=4&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3892028&THISHREF=http://c.moreover.com/click/here.pl%3fz2460017347%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmaceutical Online: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890776&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890776&THISHREF=http://c.moreover.com/click/here.pl%3fz2459367468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3890776&HITNO=5&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3890776&THISHREF=http://c.moreover.com/click/here.pl%3fz2459367468%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889415&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889415&THISHREF=http://c.moreover.com/click/here.pl%3fz2458730237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3889415&HITNO=6&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3889415&THISHREF=http://c.moreover.com/click/here.pl%3fz2458730237%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886162&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886162&THISHREF=http://c.moreover.com/click/here.pl%3fz2457650775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886162&HITNO=7&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886162&THISHREF=http://c.moreover.com/click/here.pl%3fz2457650775%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Antonio Business Journal: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886148&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886148&THISHREF=http://c.moreover.com/click/here.pl%3fz2457647524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886148&HITNO=8&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886148&THISHREF=http://c.moreover.com/click/here.pl%3fz2457647524%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSan Francisco Business Times: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886146&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886146&THISHREF=http://c.moreover.com/click/here.pl%3fz2457645940%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886146&HITNO=9&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886146&THISHREF=http://c.moreover.com/click/here.pl%3fz2457645940%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPortland Business Journal: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886115&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886115&THISHREF=http://c.moreover.com/click/here.pl%3fz2457637738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886115&HITNO=10&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886115&THISHREF=http://c.moreover.com/click/here.pl%3fz2457637738%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiz Journals: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886005&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886005&THISHREF=http://c.moreover.com/click/here.pl%3fz2457609613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3886005&HITNO=11&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3886005&THISHREF=http://c.moreover.com/click/here.pl%3fz2457609613%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comAustin Business Journal: For the Treatment of Alzheimer's Disease, Pfizer/Medivation's Dimebon Will Garner Peak Year Sales of $1.5 Billionhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885711&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885711&THISHREF=http://c.moreover.com/click/here.pl%3fz2457526014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=3885711&HITNO=12&MSIZE=13&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=Ebixa&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=3885711&THISHREF=http://c.moreover.com/click/here.pl%3fz2457526014%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR Newswire: